Early biologic treatment in Crohn’s Disease: Shining a light on SEAVUE

Learning objectives:

After this event, participants should be able to:

• Determine how the management of CD is evolving and how to select targets and optimize treatment strategies in CD
• Discuss the results of the SEAVUE trial
• Examine the implications of the SEAVUE trial on management strategies for CD

Speakers:

• Matthieu Allez, France
• Silvio Danese, Italy
• Peter Irving, UK